Early Experience With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in the United States

This survey study evaluates the early post–US Food and Drug Administration approval experience with an embolic protection device used during transcatheter aortic valve replacement procedures.

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Intern Med
Main Authors: Alkhouli, Mohamad, Alqahtani, Fahad, Harris, Alyssa Hartsell, Hohmann, Samuel F., Rihal, Charanjit S.
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2020
Assuntos:
Research Letter
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042802/
https://ncbi.nlm.nih.gov/pubmed/32091552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.6767
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares